Endrisone (INN) (brand name Aldrisone), or endrysone (USAN), is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI.[1][2][3] It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively.[1][2]
Clinical data | |
---|---|
Trade names | Aldrisone |
Other names | Delta-medrysone;[1] 6α-Methyl-11β-hydroxypregna-1,4-diene-3,20-dione; 6α-Methyl-11β-hydroxy-Δ1-progesterone |
Routes of administration | Topical, ophthalmic[1][2] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.587 |
Chemical and physical data | |
Formula | C22H30O3 |
Molar mass | 342.479 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ a b c d Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 486–. ISBN 978-1-4757-2085-3.
- ^ a b c Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 110–. ISBN 978-94-011-4439-1.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 386–. ISBN 978-3-88763-075-1.